Showing results (71-80 of 192) with videos related to
Sort By:
Pageof 20
Journal of Clinical Pharmacy and Therapeutics|December 21, 2000
Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot studyC F Green, D R Mottram, P H Rowe, et al.Journal of Clinical Pharmacy and Therapeutics|August 3, 2006
Adverse drug reactions in hospital in-patients: a pilot studyE C Davies, C F Green, D R Mottram, et al.British Journal of Clinical Pharmacology|February 1, 1992
Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivityM Pirmohamed, N R Kitteringham, A M Breckenridge, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
Metabolism and bioactivation of clozapine by human liver in vitroM Pirmohamed, D Williams, S Madden, et al.Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1992
Regulation of tumor necrosis factor production in healthy humans and in patients with cancerD B Gough, F P Winstanley, K C Fearon, et al.Journal of Medical Microbiology|June 1, 1984
Absence of bactericidal antibodies against Group-I lipopolysaccharide determinants of Neisseria gonorrhoeae during human infectionC C Blackwell, F P Winstanley, D M Weir, et al.Postgraduate Medical Journal|February 1, 1990
Adverse effects of captopril in hospital outpatients with hypertensionT Walley, P Winstanley, D Roberts, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthaleneN R Kitteringham, C Davis, N Howard, et al.Metabolic Brain Disease|September 1, 1990
Synaptic membrane complex carbohydrates in experimental hepatic encephalopathyM Rössle, F P Winstanley, K Haag, et al.Journal of Pharmaceutical and Biomedical Analysis|August 23, 2001
LC determination of carbamazepine in murine brainA Owen, J N Tettey, P Morgan, et al.Pageof 20